{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#webpage",
"url": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study",
"name": "Deploying eCOA to Improve Patient Retention and Compliance in a Phase III Asthma Study ",
"description": "Explore how eCOA solutions improved patient retention and compliance in a global Phase III asthma clinical trial. Learn how digital tools such as eDiaries, patient apps, and home-based monitoring devices helped reduce patient burden while maintaining strong protocol adherence. Discover how a balanced approach combining remote data capture with site oversight enhanced engagement, minimized dropout risk, and improved overall data quality. Through Fortrea Insights, understand how patient-centric digital strategies can drive better outcomes and efficiency in modern clinical trials in this Fortrea case study."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Deploying eCOA to Improve Patient Retention and Compliance in a Phase III Asthma Study",
"item": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#webpage"
},
"headline": "eCOA Asthma: Improving Patient Retention & Compliance in Phase III Trials | Fortrea Case Study",
"description": "Explore how eCOA solutions improved patient retention and compliance in a global Phase III asthma clinical trial. Learn how digital tools such as eDiaries, patient apps, and home-based monitoring devices helped reduce patient burden while maintaining strong protocol adherence. Discover how a balanced approach combining remote data capture with site oversight enhanced engagement, minimized dropout risk, and improved overall data quality. Through Fortrea Insights, understand how patient-centric digital strategies can drive better outcomes and efficiency in modern clinical trials in this Fortrea case study.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-10-20",
"dateModified": "2025-10-20",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-10/fortrea-ecoa-asthma-case-study.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#webpage",
"url": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study",
"name": "Deploying eCOA to Improve Patient Retention and Compliance in a Phase III Asthma Study ",
"description": "Explore how eCOA solutions improved patient retention and compliance in a global Phase III asthma clinical trial. Learn how digital tools such as eDiaries, patient apps, and home-based monitoring devices helped reduce patient burden while maintaining strong protocol adherence. Discover how a balanced approach combining remote data capture with site oversight enhanced engagement, minimized dropout risk, and improved overall data quality. Through Fortrea Insights, understand how patient-centric digital strategies can drive better outcomes and efficiency in modern clinical trials in this Fortrea case study."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Deploying eCOA to Improve Patient Retention and Compliance in a Phase III Asthma Study",
"item": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/deploying-ecoa-improve-patient-retention-and-compliance-phase-iii-asthma-study#webpage"
},
"headline": "eCOA Asthma: Improving Patient Retention & Compliance in Phase III Trials | Fortrea Case Study",
"description": "Explore how eCOA solutions improved patient retention and compliance in a global Phase III asthma clinical trial. Learn how digital tools such as eDiaries, patient apps, and home-based monitoring devices helped reduce patient burden while maintaining strong protocol adherence. Discover how a balanced approach combining remote data capture with site oversight enhanced engagement, minimized dropout risk, and improved overall data quality. Through Fortrea Insights, understand how patient-centric digital strategies can drive better outcomes and efficiency in modern clinical trials in this Fortrea case study.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-10-20",
"dateModified": "2025-10-20",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-10/fortrea-ecoa-asthma-case-study.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Case Study